Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Dimmock, Nigel J ^a   Dove, Brian K ^b   Scott, Paul D ^a   Meng, Bo ^a   Taylor, Irene ^b   Cheung, Linda ^a   Hallis, Bassam ^b   Marriott, Anthony C ^a,b   Carroll, Miles W ^b   Easton, Andrew J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

244 DI RNA; UNCLASSIFIED DRUG; VIRUS RNA;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DEFECTIVE INTERFERING INFLUENZA A VIRUS; DRUG EFFICACY; FERRET; FEVER; HEMAGGLUTINATION; IMMUNE RESPONSE; INFLUENZA VIRUS; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGEN LOAD; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SINGLE DRUG DOSE; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS PARTICLE; WEIGHT REDUCTION;

ANIMALS; DEFECTIVE VIRUSES; FERRETS; INFLUENZA A VIRUS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS;

ANIMALIA; AVES; CANIS FAMILIARIS; EQUIDAE; INFLUENZA A VIRUS; MUS; MUSTELA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84871251020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049394     Document Type: Article

References (56)

1. Laver G, Garman E, (2002) Pandemic influenza: its origin and control. Microbes and Infection 4: 1309-1316.
2. Taubenberger J, Morens D, (2008) The pathology of influenza virus infections. Annual Review of Pathology: Mechanisms of Disease 3: 499-522.
3. Webster RG, Walker EJ, (2003) Influenza- the world is teetering on the edge of a pandemic that could kill a large fraction of the human population. American Scientist 91: 122-129.
4. Cox NJ, Bridges CB, (2007) Inactivated and live attenuated influenza vaccines in young children- how do they compare? N Engl J Med 356: 729-731.
5. Nichol KL, (2008) Efficacy and effectiveness of influenza vaccination. Vaccine 26: D17-D22.
6. Treanor JJ, (2004) Influenza vaccine- outmaneuvering antigenic shift and drift. N Engl J Med 350: 218-220.
7. Smith J, Dutkowski R, Ward P, (2006) Antivirals for influenza in healthy adults. Lancet 367: 1571.
8. Colman PM, (2009) New antivirals and drug resistance. Ann Rev Biochem 78: 95-118.
9. Oxford JS, (2007) Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza and Other Respiratory Viruses 1: 27-34.
10. Jefferson T, Rivetti D, Rudin M, Di Pietrantonj C, Demicheli V, (2005) Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366: 1165-1174.
11. Webster RG, (2000) Immunity to influenza in the elderly. Vaccine 18: 1686-1689.
12. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O, (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerging Infect Dis 15: 155-162.
13. Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, et al. (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerging Infect Dis 15: 552-560.
14. Duan S, Boltz DA, Seiler P, Li J, Bragstad K, et al. (2010) Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathogens 6: 1001022.
15. Hamelin M-E, Baz M, Abed Y, Couture C, Joubert P, et al. (2010) Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathogens 6: 1001015.
16. Ujike M, Ejima M, Anraku A, Shimabukuro K, Obuchi M, et al. (2011) Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010. Emerging Infect Dis 17: 470-479.
17. Huang AS, Baltimore D, (1970) Defective viral particles and viral disease processes. Nature (Lond) 226: 325-327.
18. Barrett ADT, Dimmock NJ, (1986) Defective interfering viruses and infections of animals. Curr Topics Microbiol Immunol 128: 55-84.
19. Gard S, von Magnus P, (1947) Studies on interference in experimental influenza. II Purification and centrifugation experiments. Arkiv fur Kemi Mineralogi och Geologi 24b: 1-4.
20. von Magnus P, (1954) Incomplete forms of influenza virus. Adv Virus Res 21: 59-79.
21. Jennings PA, Finch JT, Winter G, Robertson JS, (1983) Does the higher order of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA. Cell 34: 619-627.
22. Duhaut SD, Dimmock NJ, (1998) Heterologous protection against a lethal human H1N1 influenza virus infection of mice by a H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Virol 248: 241-253.
23. Dimmock NJ, Rainsford EW, Scott PD, Marriott AC, (2008) Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 82: 8570-8578.
24. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ, (2011) Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Vaccine 29: 6584-6591.
25. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ, (2011) Defective interfering virus protects elderly mice from influenza. Virology Journal 8: 212.
26. Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ, (2011) DI influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. J Gen Virol 92: 2122-2132.
27. Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, et al. (2011) A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 29: 2777-2784.
28. Huang AS, (1973) Defective interfering viruses. Ann Rev Microbiol 27: 101-117.
29. Duhaut S, McCauley JW, (1996) Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virol 216: 326-337.
30. Smith W, Andrewes CH, Laidlaw PP, (1933) A virus obtained from influenza patients. Lancet 2: 66-68.
31. Francis T, (1934) Transmission of influenza by a filterable virus. Science 80: 457-459.
32. Sweet C, Smith H, (1980) Pathogenicity of influenza virus. Microbiol Rev 44: 303-330.
33. Barnard DL, (2009) Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 82: A110-A120.
34. van den Brand JMA, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, et al. (2010) Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 201: 993-999.
35. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, et al. (2008) Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 82: 11308-11317.
36. Herlocher ML, Elias S, Truscon R, Harrison S, Mindell D, et al. (2001) Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. J Infect Dis 184: 542-546.
37. Maines T, Jayaraman A, Belser J, Wadford D, Pappas C, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A (H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
38. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1020-1025.
39. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, et al. (2005) Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 79: 2191-2198.
40. Maines T, Lu XH, Erb SM, Edwards L, Guarner J, et al. (2005) Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 79: 11788-11800.
41. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al. (2006) H5N1 virus attachment to lower respiratory tract. Science 312: 399.
42. Layton RC, Armijo P, Myers L, Knight J, Donart N, et al. (2009) Ferret model of avian influenza demonstrates dose and strain dependent pathology and viral load in brain. Procedings in Vaccinology 1: 30-34.
43. Lednicky JA, Hamilton SB, Tuttle RS, Sosna WA, Daniels DE, et al. (2010) Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A/Vietnam/1203/2004 (H5N1). Virology Journal 7: 231.
44. Tellier R, (2009) Aerosol transmission of influenza A virus: a review of new studies. Journal of the Royal Society Interface 6 (Suppl 6):: S783-S790.
45. Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, et al. (2008) Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virol 374: 198-209.
46. Govorkova EA, Ilyushina NA, Smith J, Webster RG, (2006) Oseltamivir protects ferrets against lethal H5N1 influenza virus infection. Antiviral Res 70: A29.
47. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA, (2006) Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infect Immun 74: 2562-2567.
48. Mann A, Marriott AC, Balasingam S, Lambkin R, Oxford JS, et al. (2006) Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. Vaccine 24: 4290-4296.
49. Meng B, Marriott AC, Dimmock NJ, (2010) The receptor preferences of influenza viruses. Influenza & Other Respiratory Viruses 4: 147-153.
50. Govorkova EA, Marathe BM, Prevost A, Rehg JE, Webster RG, (2011) Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets. Antiviral Res 91: 81-88.
51. Maines T, Belser J, Gustin KM, von Hoeven N, Zeng H, et al. (2012) Local innate immune responses and influenza virus transmission and virulence in ferrets. J Infect Dis 205: 474-485.
52. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, et al. (2003) Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate by plasmid-based reverse genetics. Virol 305: 192-200.
53. Leigh MW, Connor RJ, Kelm S, Baum L, Paulson JC, (1995) Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine 13: 1468-1473.
54. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, et al. (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171: 1215-1223.
55. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, et al. (2006) Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80: 7469-80.
56. Hirst GK, (1941) The agglutination of red blood cells by allantoic fluid of chick embryos infected with influenza virus. Science 94: 22-23.